samedan logo
 
 
spacer
home > pmps > summer 2003 > capsule technology to optimise drug delivery
PUBLICATIONS
Pharmaceutical Manufacturing and Packing Sourcer

Capsule Technology to Optimise Drug Delivery

While it seems that a new drug launch draws all the attention to the specific drug substance, it is clear that the authorities only approve a drug product which contains more than just the specific drug substance alone. In reality, the drug product is a combination of the drug, a formulation of functional excipients and their processing. The formulation and processing is critical for the pharmacokinetic profile of the drug substance in vivo, which is part of its efficacy and safety. The optimal efficacy and safety is dependent on the drug concentration at the receptor site, the input rate and the duration of receptor interaction. In a recent draft guideline the FDA addresses the need to evaluate the pharmacokinetic-pharmacodynamic correlation to develop the optimal drug delivery system in terms of maximised efficacy and safety profile for the drug substance (1).

According to the Biopharmaceutics Drug Classification (BCS), drugs are classified according to their aqueous solubility and membrane permeability (2). Drugs with poor solubility but high permeability are classified as 'Class 2' compounds. Their oral bioavailability can be expected to be dependent on the solubilisation kinetic in the gastric juice of the GI tract.

A formulation for a 'Class 2' drug will focus on solubility enhancement or solubilisation to improve the bioavailability and pharmacokinetic profile. Many different technologies have been proposed, especially particle size reduction to the nanometer range and solid dispersions. About a decade ago, self-emulsifying drug delivery systems (DDS) entered into the pharmaceutical development scene as a potential technology to enhance oral bioavailability.


Read full article >>

Rate this article You must be a member of the site to make a vote.  
Average rating:
0
     

There are no comments in regards to this article.

spacer
By Sven Stegemann, Business Development Manager for Europe, Middle East and Africa at Capsugel

Sven Stegemann is a Pharmacist by education and gained his PhD in Pharmacology from the University of Frankfurt in 1992 before beginning his work in the pharmaceutical industry. Over the years he has worked in galenical development, production, regulatory affairs and licensing. In 1997 Sven joined Capsugel as a Business Development Manager for Europe, Middle East and Africa. In this position he works closely with the pharmaceutical industry on the development of optimised formulation and drug delivery systems. He is active in various organisations (in positions such as Vice President of the EAPB and Member of the CIR group of the EUFEPS.

spacer
Sven Stegemann
spacer
spacer
Print this page
Send to a friend
Privacy statement

Industry Events

EMBALLAGE 2008. World Packaging Exhibition

16-21 November 2008, Paris-Nord Villepinte - France

“Business, Innovation, Outlook” are the watchwords for the 38th World Packaging Exhibition which opens in Paris from 17 to 21 November 2008. Fifteen months before the key packaging event of the end of 2008, EMBALLAGE displays its differences to offer you a new edition that is even more representative, international and rich in new features.
More info >>

 
News and Press Releases

Ultra slim and ultra quick


More info >>

 

©2000-2007 Samedan Ltd.
About Us | Register | Login | Site Map | Terms and Conditions | Contact Us |
Add to favourites

Print this page

Send to a friend
Privacy statement